The call to reduce market entry times for life-saving new drug therapies is becoming more urgent. What constitutes best practice in managing translations in today’s regulatory affairs environment? Nancy Pollini reports.
Nancy Pollini
Advertisement
Nancy Pollini is director of strategic accounts for language services at AMPLEXOR Life Sciences.
Articles by Nancy Pollini
Advertisement
Latest Updated Articles
Managing Local Language Regulatory SubmissionsPublished: September 27th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Announces Major Shake Ups to Board
2
Shifting Focus in Autoimmune Diseases
3
FDA Accepts Tzield for Expedited Review Under The Commissioner’s National Priority Voucher Program
4
Pharmaceutical Executive Daily: Merck's $70 Billion Investment
5
